68-year-old male. HCC, cirrhosis, HCV. Status post TACE/RFA. Evaluate liver lesions. ABDOMEN:LIVER, BILIARY TRACT: Ablation defect in the right hepatic lobe measures 1.8 x 3.6 cm (series 9, image 136). There is a anterior and superior peripheral nodule of arterial enhancement in the cavity measuring 1.1 x 0.9 cm (series 9, image 40), concerning for residual tumor. New 1.2 x 1.3 cm arterial focus of enhancement in segment 6 (series 9, image 55) that becomes isointense to liver parenchyma on later phases and does not have associated T2 signal abnormality; does meet criteria for HCC, special attention on follow-up scans.No biliary ductal dilatation. Patent hepatic artery, hepatic vein, and portal vein. Cirrhotic liver morphology.SPLEEN: No significant abnormality noted.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Mildly atrophic kidneys.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: Small hiatal hernia.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1. Interval ablation of segment 8 lesion with a small nodular focus of arterial enhancement in the ablation cavity concerning for residual tumor. 2. New 1.2 cm arterially enhancing focus in segment 6 that does meet criteria for HCC; special attention on follow-up scans.